Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | tyrosyl-DNA phosphodiesterase | 0.0071 | 0.1082 | 0.1082 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0098 | 0.1691 | 0.6693 |
Loa Loa (eye worm) | hypothetical protein | 0.0474 | 1 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0032 | 0.0227 | 0.0897 |
Schistosoma mansoni | tyrosyl-DNA phosphodiesterase | 0.0071 | 0.1082 | 0.4284 |
Schistosoma mansoni | tar DNA-binding protein | 0.0136 | 0.2526 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0474 | 1 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0193 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.0136 | 0.2526 | 1 |
Onchocerca volvulus | 0.0254 | 0.5125 | 0.5125 | |
Brugia malayi | Pre-SET motif family protein | 0.0223 | 0.4445 | 0.4445 |
Brugia malayi | RNA binding protein | 0.0136 | 0.2526 | 0.2526 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0032 | 0.0227 | 0.0897 |
Brugia malayi | TAR-binding protein | 0.0136 | 0.2526 | 0.2526 |
Schistosoma mansoni | tar DNA-binding protein | 0.0136 | 0.2526 | 1 |
Brugia malayi | hypothetical protein | 0.003 | 0.0193 | 0.0193 |
Echinococcus multilocularis | tyrosyl DNA phosphodiesterase 1 | 0.0071 | 0.1082 | 0.4284 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0227 | 0.0227 |
Echinococcus multilocularis | transcription factor Dp 1 | 0.0041 | 0.0424 | 0.168 |
Plasmodium vivax | SET domain protein, putative | 0.0032 | 0.0227 | 1 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0031 | 0.0201 | 0.0794 |
Loa Loa (eye worm) | TAR-binding protein | 0.0136 | 0.2526 | 0.2526 |
Schistosoma mansoni | tar DNA-binding protein | 0.0136 | 0.2526 | 1 |
Brugia malayi | Tyrosyl-DNA phosphodiesterase family protein | 0.0071 | 0.1082 | 0.1082 |
Leishmania major | tyrosyl-DNA phosphodiesterase 1 | 0.0071 | 0.1082 | 1 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0071 | 0.1082 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0136 | 0.2526 | 1 |
Echinococcus granulosus | transcription factor Dp 1 | 0.0041 | 0.0424 | 0.168 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0032 | 0.0227 | 0.0897 |
Loa Loa (eye worm) | RNA binding protein | 0.0136 | 0.2526 | 0.2526 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0032 | 0.0227 | 0.0897 |
Trypanosoma brucei | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0071 | 0.1082 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0098 | 0.1691 | 0.6693 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0098 | 0.1691 | 0.6693 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0136 | 0.2526 | 0.2526 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0098 | 0.1691 | 0.6693 |
Loa Loa (eye worm) | runx1 | 0.006 | 0.0835 | 0.0835 |
Echinococcus granulosus | tar DNA binding protein | 0.0136 | 0.2526 | 1 |
Onchocerca volvulus | 0.0032 | 0.0227 | 0.0227 | |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0032 | 0.0227 | 0.0897 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0098 | 0.1691 | 0.1691 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0136 | 0.2526 | 0.2526 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0032 | 0.0227 | 1 |
Schistosoma mansoni | lozenge | 0.006 | 0.0835 | 0.3305 |
Brugia malayi | Pre-SET motif family protein | 0.0032 | 0.0227 | 0.0227 |
Trichomonas vaginalis | set domain proteins, putative | 0.0254 | 0.5125 | 0.5 |
Echinococcus granulosus | tyrosyl DNA phosphodiesterase 1 | 0.0071 | 0.1082 | 0.4284 |
Schistosoma mansoni | tar DNA-binding protein | 0.0136 | 0.2526 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0098 | 0.1691 | 0.6693 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0098 | 0.1691 | 0.6693 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0071 | 0.1082 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0098 | 0.1691 | 0.6693 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0032 | 0.0227 | 0.0897 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0223 | 0.4445 | 0.4445 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0193 | 0.5 |
Echinococcus multilocularis | Protein lozenge | 0.006 | 0.0835 | 0.3305 |
Entamoeba histolytica | tyrosyl-DNA phosphodiesterase, putative | 0.0071 | 0.1082 | 0.5 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0032 | 0.0227 | 0.0897 |
Onchocerca volvulus | 0.0474 | 1 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0193 | 0.0193 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0098 | 0.1691 | 0.1691 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.4467 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.